The Value of Cancer Trials Report was launched today at a well-attended hybrid event bringing together members of the cancer research, clinical and patient communities, along with industry and funding partners. The event highlighted the life-saving and economic impact of cancer trials in Ireland, showing how they improve outcomes, reduce costs, and bring innovative treatments to patients.
Speakers emphasised the need for sustained government investment and faster, more consistent trial processes to ensure every patient in Ireland can access trials as part of standard cancer care. The report demonstrates that the true value of trials extends far beyond medicine — improving quality of life, strengthening the health system, and delivering significant returns to the State. Read the full report below: